Results 131 to 140 of about 430,871 (256)

Knowledge of human papilloma virus and vaccine hesitancy among health sciences students in Türkiye

Scientific Reports
Vaccine hesitancy among health sciences students has become a growing public health concern, particularly regarding the human papillomavirus (HPV), the most prevalent sexually transmitted infection globally.
Eda Unal
doaj   +1 more source

Efficacy Of The Quadrivalent HPV Vaccine In Cervical Cancer Prevention Strategy In The Gambia

, 2017
Background and Objective: Persistent infection with high risk Human Papillomavirus (HR HPV) genotype causes 80% of cervical cancers. HR HPV 16 and 18 are responsible for 70% of cervical cancer cases, worldwide.
Anyanwu, M., Banja, F., Mboob-Suun, K., Wright, E., Kimmitt, P.T., Ceesay, F., Bah Camara, H.   +6 more
core  

Uptake of human papillomavirus vaccine among school girls and its associated factors in Addis Ababa, Ethiopia

SAGE Open Medicine
Objectives To assess the HPV vaccine uptake among adolescent public high school girls aged 15-19 years and the factors associated with it in Addis Ababa, Ethiopia.
Aklilu Feleke Haile, Yemane Berhane
doaj   +1 more source

HPV vaccine for boys [PDF]

British Dental Journal, 2014
openaire   +2 more sources

Cell cycle control and its modulation in HPV infected cells [PDF]

, 2010
A key effect of human papillomavirus (HPV) infection is to disrupt the normal cell cycle in order to subvert the cellular DNA replication machinery. Morphologically, condylomata induced by high and low risk HPV types cannot be distinguished and many ...
Lyman, Rachel C.
core  

Adjuvant HPV Vaccination and Survival in Oropharyngeal Squamous Cell Carcinoma: An Exploratory Analysis of a Real‐World Database

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
HPV vaccination after exposure may confer survival benefits in oropharyngeal cancer patients. Survival advantages appeared regardless of vaccination timing relative to diagnosis, though small sample sizes preclude definitive conclusions. ABSTRACT Objective Childhood HPV vaccination reduces oropharyngeal cancer (OPC) incidence, but evidence regarding ...
Mary Elizabeth Kim, Kevin Herrera, Albert Han, Kevin Hur, Niels Kokot, Mark S. Swanson   +5 more
wiley   +1 more source

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2041-2047, October 2026.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine : combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

, 2015
: Background There is some evidence to suggest that one or two doses of the HPV vaccine provides similar protection to the three-dose regimen. The main aim of the study was to ascertain HPV-16/18 vaccine efficacy in both full and naive cohorts and to ...
Wacholder, Sholom, Struyf, Frank, Herrero, Rolando, Hildesheim, Allan, Skinner, S. Rachel, David, Marie-Pierre, Tjalma, Wiebren, Costa Rica Vaccine Trial, Kreimer, Aim\ue9e R., Del Rosario-Raymundo, Maria Rowena, Garland, Suzanne M., PATRICIA study groups, Wheeler, Cosette M.   +12 more
core  

Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2104-2113, October 2026.
This study demonstrates that women's experiences following an hrHPV diagnosis within cervical screening extend beyond individual reactions to medical information, encompassing complex psychological, social, and cultural dimensions that influence how women interpret and manage the diagnosis.
Joan Hansen, Beth J. Maclin, Birgitte Folmann, Jane Ege Møller, Ane Kersti Skaarup Knudsen, Vibeke Raaby, Anne Hammer   +6 more
wiley   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page 1412-1416, October 2026.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source